Mirabegron for Female OAB Patients: Comparison of Daytime and Nighttime Dosing
NCT03251300
·
clinicaltrials.gov ↗
PHASE4
Phase
UNKNOWN
Status
120
Enrollment
OTHER
Sponsor class
Conditions
Overactive Bladder Syndrome
Interventions
DRUG:
daytime dosing of mirabegron
DRUG:
nighttime dosing of mirabegron
Sponsor
Far Eastern Memorial Hospital